Magnesium is a cofactor in more than 300 enzymatic reactions — including every step of ATP synthesis, DNA replication, RNA transcription, and protein synthesis. It is the second most abundant intracellular cation (after potassium) and the fourth most abundant mineral in the human body. It is also, by NHANES data, one of the most prevalent nutrient deficiencies in the United States, with 68% of American adults failing to meet the Estimated Average Requirement (EAR) through diet.
The magnesium supplement market is simultaneously one of the most useful and one of the most confusing supplement categories — useful because deficiency is genuinely prevalent and has real clinical consequences; confusing because the form of magnesium matters enormously for bioavailability and tissue targeting, and most supplement labels give no guidance on form-outcome matching. Magnesium oxide (the cheapest and most commonly sold form) has approximately 4% bioavailability. Magnesium glycinate has approximately 80% bioavailability. These are not equivalent products despite containing the same elemental mineral.
| Form | Bioavailability | Best For | Key Notes |
|---|---|---|---|
| Magnesium Oxide | ~4% | Constipation only (osmotic laxative effect) | Most common form in cheap supplements; avoid for systemic magnesium benefits; nearly inert nutritionally; only 4% absorbed → 96% passes through → laxative effect at standard doses |
| Magnesium Citrate | ~30% | General repletion; constipation | Better than oxide; widely available; mild laxative effect at higher doses; good entry-level option if cost is primary concern |
| Magnesium Glycinate | ~80% | Sleep, anxiety, muscle relaxation, general repletion | Chelated form (magnesium bound to glycine amino acid); glycine itself has sleep-promoting and anxiolytic properties; gentle on GI; minimal laxative effect; preferred for most people supplementing for sleep, anxiety, or general magnesium repletion; most recommended form for daily use |
| Magnesium L-Threonate (Magtein) | ~80% systemically; superior CNS penetration | Cognitive function, memory, brain health | MIT patent; Slutsky 2010 (Neuron): only form shown to increase brain magnesium levels in animal models (7–15% increase vs other forms); mechanism: threonate is a metabolite of vitamin C that may enhance magnesium transport across blood-brain barrier; human data limited vs animal data; Liu 2016 (J Alzheimers Dis, N=44): cognitive improvement in older adults; most expensive form; justified if specifically targeting cognitive health |
| Magnesium Malate | ~80% | Energy, muscle function, fibromyalgia | Magnesium bound to malic acid (Krebs cycle intermediate); malic acid enhances ATP production; studied in fibromyalgia; good for athletes or those with fatigue as primary complaint; similar bioavailability to glycinate |
| Magnesium Taurate | ~80% | Cardiovascular health, blood pressure | Magnesium + taurine; taurine has independent cardiovascular benefits (reduces BP, antiarrhythmic); synergistic combination for cardiovascular applications; good choice if targeting blood pressure or heart rate regulation |
| Magnesium Chloride (topical) | Variable, not well-quantified | Transdermal delivery debate | Magnesium oil/flakes for baths; transdermal absorption is real but clinically debated — skin is a barrier, not a membrane; likely contributes to local tissue magnesium without meaningful systemic repletion; complementary to oral, not a replacement |
For sleep improvement: Magnesium glycinate 300–400mg, taken 30–60 minutes before bed; glycine component (typically ~200mg glycine in a 400mg glycinate dose) has independent sleep-promoting effects (core body temperature reduction, NMDA receptor modulation); evidence: Abbasi 2012 (J Res Med Sci, N=46): 500mg magnesium improved ISI (Insomnia Severity Index) score, subjective sleep quality, and morning melatonin; stack with glycine 3g separately if targeting deeper sleep further.
For anxiety and stress reduction: Magnesium glycinate 200–400mg/day; mechanism: magnesium blocks NMDA glutamate receptors (reducing excitatory neurotransmission) and modulates HPA axis stress response; Boyle 2017 (Nutrients): systematic review of 18 studies — mild-to-moderate anxiolytic effect in magnesium supplementation; most studies used citrate or glycinate forms; glycinate preferred for anxiety due to glycine's GABAergic effects.
For blood pressure: Magnesium 300–500mg/day (citrate, glycinate, or taurate); taurate preferred if specifically targeting cardiovascular system (taurine's synergistic CV benefits); allow 8–12 weeks for meaningful blood pressure effect; most effective in those with hypertension and baseline magnesium deficiency; combine with potassium-rich diet and reduced sodium for additive effect.
For migraine prevention: 400–600mg/day; citrate or glycinate; minimum 3 months before assessing efficacy (migraine prevention supplements require sustained use); take with food to reduce GI discomfort at higher doses.
For cognitive health: Magnesium L-threonate (Magtein) 1500–2000mg/day (providing ~144mg elemental magnesium); dose is measured in total threonate salt, not elemental magnesium; Liu 2016 trial used 1500mg/day for 12 weeks; most expensive option — justified if brain health is primary goal, less justified for general repletion.
Safety: Magnesium is water-soluble; excess is excreted renally; GI distress (loose stool) is the practical upper limit for most people and dose-dependent; doses >350mg elemental magnesium/day from supplements should be approached cautiously; Tolerable Upper Limit set at 350mg from supplements (not counting dietary magnesium); in renal impairment, magnesium can accumulate — consult physician; typical supplement doses (200–400mg glycinate) are well-tolerated in healthy adults.
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.